Follow the people · Insider
Shankar Musunuri
Shankar Musunuri files insider transactions with the SEC as a chief executive officer of Ocugen. We hold 1 disclosed purchase or sale filed since 13 December 2019, 1 of them in the last 90 days.
- Files forOCGN
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure11 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 11 December 2019 — 9 September 2026Chief Executive Officer · Ocugen 66 Form 4 lines · source: SEC Form 4
Every transaction
66 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 9 Sep 2026 | 11 Sep 2026SEC Form 4 | 2 d | sold on the open market | Ocugen | 468,727 shares | down −4.2% | up +0.0% |
| 9 Sep 2026 | 11 Sep 2026SEC Form 4 | 2 d | sold on the open market | Ocugen | 57,264 shares | down −4.2% | up +0.0% |
| 2 Jan 2026 | 6 Jan 2026SEC Form 4 | 4 d | was grantednot a trade | Ocugen | 3,123,201 shares | down −26.1% | down −33.8% |
| 2 Jan 2026 | 6 Jan 2026SEC Form 4 | 4 d | was grantednot a trade | Ocugenderivative | 3,123,201 shares | down −26.1% | down −33.8% |
| 2 Jan 2026 | 6 Jan 2026SEC Form 4 | 4 d | was grantednot a trade | Ocugenderivative | 3,123,201 shares | down −26.1% | down −33.8% |
| 2 Jan 2026 | 6 Jan 2026SEC Form 4 | 4 d | was grantednot a trade | Ocugen | 3,123,201 shares | down −26.1% | down −33.8% |
| 3 Jan 2025 | 6 Jan 2025SEC Form 4 | 3 d | had shares withheld for taxnot a trade | Ocugen | 177,146 shares | up +14.0% | up +13.3% |
| 2 Jan 2025 | 6 Jan 2025SEC Form 4 | 4 d | was grantednot a trade | Ocugenderivative | 1,827,485 shares | up +13.3% | up +13.3% |
| 3 Jan 2024 | 5 Jan 2024SEC Form 4 | 2 d | had shares withheld for taxnot a trade | Ocugen | 180,204 shares | up +56.2% | up +52.5% |
| 2 Jan 2024 | 4 Jan 2024SEC Form 4 | 2 d | was grantednot a trade | Ocugenderivative | 492,126 shares | up +55.0% | up +56.2% |
| 16 Feb 2023 | 17 Feb 2023SEC Form 4 | 1 d | exercised options overnot a trade | Ocugenderivative | 100,000 shares | down −1.9% | down −5.6% |
| 16 Feb 2023 | 17 Feb 2023SEC Form 4 | 1 d | exercised options overnot a trade | Ocugen | 100,000 shares | down −1.9% | down −5.6% |
| 16 Feb 2023 | 17 Feb 2023SEC Form 4 | 1 d | sold on the open market | Ocugen | 100,000 shares | down −1.9% | down −5.6% |
| 17 Jan 2023 | 19 Jan 2023SEC Form 4 | 2 d | exercised options overnot a trade | Ocugenderivative | 100,000 shares | down −19.0% | down −12.1% |
| 17 Jan 2023 | 19 Jan 2023SEC Form 4 | 2 d | exercised options overnot a trade | Ocugen | 100,000 shares | down −19.0% | down −12.1% |
| 17 Jan 2023 | 19 Jan 2023SEC Form 4 | 2 d | sold on the open market | Ocugen | 100,000 shares | down −19.0% | down −12.1% |
| 3 Jan 2023 | 17 Feb 2023SEC Form 4 | 45 d | had shares withheld for taxnot a trade | Ocugen | 37,877 shares | down −18.4% | down −5.6% |
| 3 Jan 2023 | 5 Jan 2023SEC Form 4 | 2 d | was grantednot a trade | Ocugenderivative | 1,771,654 shares | down −18.4% | down −20.9% |
| 3 Jan 2023 | 5 Jan 2023SEC Form 4 | 2 d | was grantednot a trade | Ocugen | 1,475,410 shares | down −18.4% | down −20.9% |
| 16 Dec 2022 | 20 Dec 2022SEC Form 4 | 4 d | exercised options overnot a trade | Ocugenderivative | 95,809 shares | down −33.3% | down −22.7% |
| 16 Dec 2022 | 20 Dec 2022SEC Form 4 | 4 d | exercised options overnot a trade | Ocugen | 95,809 shares | down −33.3% | down −22.7% |
| 16 Dec 2022 | 20 Dec 2022SEC Form 4 | 4 d | sold on the open market | Ocugen | 95,809 shares | down −33.3% | down −22.7% |
| 14 Oct 2022 | 14 Oct 2022SEC Form 4 | 0 d | exercised options overnot a trade | Ocugenderivative | 100,000 shares | down −34.6% | down −34.6% |
| 14 Oct 2022 | 14 Oct 2022SEC Form 4 | 0 d | exercised options overnot a trade | Ocugen | 100,000 shares | down −34.6% | down −34.6% |
| 14 Oct 2022 | 14 Oct 2022SEC Form 4 | 0 d | sold on the open market | Ocugen | 100,000 shares | down −34.6% | down −34.6% |
| 14 Jul 2022 | 15 Jul 2022SEC Form 4 | 1 d | exercised options overnot a trade | Ocugenderivative | 150,000 shares | down −61.2% | down −60.5% |
| 14 Jul 2022 | 15 Jul 2022SEC Form 4 | 1 d | exercised options overnot a trade | Ocugen | 150,000 shares | down −61.2% | down −60.5% |
| 14 Jul 2022 | 15 Jul 2022SEC Form 4 | 1 d | sold on the open market | Ocugen | 150,000 shares | down −61.2% | down −60.5% |
| 13 May 2022 | 13 May 2022SEC Form 4 | 0 d | exercised options overnot a trade | Ocugenderivative | 125,000 shares | down −51.4% | down −51.4% |
| 13 May 2022 | 13 May 2022SEC Form 4 | 0 d | exercised options overnot a trade | Ocugen | 125,000 shares | down −51.4% | down −51.4% |
| 13 May 2022 | 13 May 2022SEC Form 4 | 0 d | sold on the open market | Ocugen | 125,000 shares | down −51.4% | down −51.4% |
| 16 Mar 2022 | 18 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Ocugenderivative | 81,823 shares | down −64.5% | down −72.6% |
| 16 Mar 2022 | 18 Mar 2022SEC Form 4 | 2 d | exercised options overnot a trade | Ocugen | 81,823 shares | down −64.5% | down −72.6% |
| 16 Mar 2022 | 18 Mar 2022SEC Form 4 | 2 d | sold on the open market | Ocugen | 81,823 shares | down −64.5% | down −72.6% |
| 14 Feb 2022 | 16 Feb 2022SEC Form 4 | 2 d | exercised options overnot a trade | Ocugenderivative | 90,000 shares | down −72.0% | down −73.3% |
| 14 Feb 2022 | 16 Feb 2022SEC Form 4 | 2 d | exercised options overnot a trade | Ocugen | 90,000 shares | down −72.0% | down −73.3% |
| 14 Feb 2022 | 16 Feb 2022SEC Form 4 | 2 d | sold on the open market | Ocugen | 90,000 shares | down −72.0% | down −73.3% |
| 3 Jan 2022 | 5 Jan 2022SEC Form 4 | 2 d | was grantednot a trade | Ocugenderivative | 1,253,299 shares | down −78.4% | down −75.6% |
| 3 Jan 2022 | 5 Jan 2022SEC Form 4 | 2 d | was grantednot a trade | Ocugen | 346,540 shares | down −78.4% | down −75.6% |
| 16 Dec 2021 | 17 Dec 2021SEC Form 4 | 1 d | was grantednot a trade | Ocugenderivative | 197,000 shares | down −79.7% | down −80.5% |
| 16 Dec 2021 | 17 Dec 2021SEC Form 4 | 1 d | sold on the open market | Ocugen | 115,000 shares | down −79.7% | down −80.5% |
| 16 Nov 2021 | 18 Nov 2021SEC Form 4 | 2 d | was grantednot a trade | Ocugenderivative | 197,000 shares | down −87.5% | down −86.0% |
| 16 Nov 2021 | 18 Nov 2021SEC Form 4 | 2 d | sold on the open market | Ocugen | 115,000 shares | down −87.5% | down −86.0% |
| 1 Nov 2021 | 3 Nov 2021SEC Form 4 | 2 d | exercised options overnot a trade | Ocugenderivative | 115,367 shares | down −92.7% | down −92.0% |
| 1 Nov 2021 | 3 Nov 2021SEC Form 4 | 2 d | exercised options overnot a trade | Ocugen | 115,367 shares | down −92.7% | down −92.0% |
| 1 Nov 2021 | 3 Nov 2021SEC Form 4 | 2 d | sold on the open market | Ocugen | 115,367 shares | down −92.7% | down −92.0% |
| 15 Oct 2021 | 15 Oct 2021SEC Form 4 | 0 d | exercised options overnot a trade | Ocugenderivative | 125,000 shares | down −88.2% | down −88.2% |
| 15 Oct 2021 | 15 Oct 2021SEC Form 4 | 0 d | exercised options overnot a trade | Ocugen | 125,000 shares | down −88.2% | down −88.2% |
| 15 Oct 2021 | 15 Oct 2021SEC Form 4 | 0 d | sold on the open market | Ocugen | 125,000 shares | down −88.2% | down −88.2% |
| 15 Sep 2021 | 17 Sep 2021SEC Form 4 | 2 d | exercised options overnot a trade | Ocugenderivative | 125,000 shares | down −86.5% | down −87.1% |
| 15 Sep 2021 | 17 Sep 2021SEC Form 4 | 2 d | exercised options overnot a trade | Ocugen | 125,000 shares | down −86.5% | down −87.1% |
| 15 Sep 2021 | 17 Sep 2021SEC Form 4 | 2 d | sold on the open market | Ocugen | 125,000 shares | down −86.5% | down −87.1% |
| 8 Jun 2021 | 9 Jun 2021SEC Form 4 | 1 d | exercised options overnot a trade | Ocugen | 22,800 shares | down −89.9% | down −89.0% |
| 8 Jun 2021 | 9 Jun 2021SEC Form 4 | 1 d | sold on the open market | Ocugen | 22,800 shares | down −89.9% | down −89.0% |
| 8 Jun 2021 | 9 Jun 2021SEC Form 4 | 1 d | exercised options overnot a trade | Ocugenderivative | 22,800 shares | down −89.9% | down −89.0% |
| 7 Jun 2021 | 9 Jun 2021SEC Form 4 | 2 d | exercised options overnot a trade | Ocugen | 7,758 shares | down −90.1% | down −89.0% |
| 7 Jun 2021 | 9 Jun 2021SEC Form 4 | 2 d | sold on the open market | Ocugen | 7,758 shares | down −90.1% | down −89.0% |
| 7 Jun 2021 | 9 Jun 2021SEC Form 4 | 2 d | exercised options overnot a trade | Ocugenderivative | 7,758 shares | down −90.1% | down −89.0% |
| 3 May 2021 | 3 May 2021SEC Form 4 | 0 d | exercised options overnot a trade | Ocugen | 195,809 shares | down −93.5% | down −93.5% |
| 3 May 2021 | 3 May 2021SEC Form 4 | 0 d | sold on the open market | Ocugen | 195,809 shares | down −93.5% | down −93.5% |
| 3 May 2021 | 3 May 2021SEC Form 4 | 0 d | exercised options overnot a trade | Ocugenderivative | 195,809 shares | down −93.5% | down −93.5% |
| 1 Jan 2021 | 4 Jan 2021SEC Form 4 | 3 d | was grantednot a trade | Ocugenderivative | 1,757,000 shares | down −44.3% | down −66.8% |
| 7 May 2020 | 7 May 2020SEC Form 4 | 0 d | was grantednot a trade | Ocugenderivative | 1,357,145 shares | up +209.1% | up +209.1% |
| 2 Jan 2020 | 3 Jan 2020SEC Form 4 | 1 d | was grantednot a trade | Ocugenderivative | 933,528 shares | up +99.6% | up +89.2% |
| 12 Dec 2019 | 13 Dec 2019SEC Form 4 | 1 d | bought on the open market | Ocugen | 143,000 shares | up +191.4% | up +200.0% |
| 11 Dec 2019 | 13 Dec 2019SEC Form 4 | 2 d | bought on the open market | Ocugen | 263,000 shares | up +172.0% | up +200.0% |
Both percentages are the stock’s move, not Shankar Musunuri’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 66 of the 66 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.